-
The National Health Insurance Bureau launched the medical insurance drug access negotiation this week
Time of Update: 2019-11-11
On November 11, reporters learned that the national health insurance bureau started a new round of negotiations on the access of Medicare drugs this week The health insurance bureau had previously pla
-
Liaoning: in the middle of December, we began to use the volume procurement to expand the scope of selected drugs
Time of Update: 2019-11-05
On November 4, 10 departments including Liaoning Medical Insurance Bureau, health care Commission and Drug Administration jointly issued the opinions on comprehensively promoting the centralized purch
-
China Resources Shuanghe subsidiary finasteride tablets passed the consistency announcement
Time of Update: 2019-09-26
On September 26, China Resources Shuanghe Pharmaceutical Co., Ltd (hereinafter referred to as "China Resources Shuanghe"), a wholly-owned subsidiary of China Resources Shuanghe Pharmaceutical Co., Ltd
-
The state health insurance bureau will optimize and perfect the bidding and purchasing system in response to the relevant suggestions on drug centralized purchase
Time of Update: 2019-09-12
On September 11, the State Health Insurance Bureau replied to the second session of the 13th National People's Congress recommendation No 6633 on improving the centralized bidding and purchasing of dr
-
First line immunotherapy for non squamous lung cancer! Tecentriq + chemotherapy protocol review of Roche tumor immunotherapy was extended by US FDA for 3 months
Time of Update: 2019-09-02
September 2, 2019 / BIOON / -- gene tech, a subsidiary of Roche, a Swiss pharmaceutical giant, recently announced that the US Food and Drug Administration (FDA) has extended the examination time of a
-
The National People's Congress held a meeting, and the latest news came from the "Drug Administration Law
Time of Update: 2019-08-16
The third trial time of "Drug Administration Law" has been set! The announcement was made by Xinhua News Agency on August 15 in Beijing The 36th meeting of chairmen of the Standing Committee of the 13
-
R & D investment 9.42 million yuan! Fosun Pharmaceutical is terminated the dm199 preparation license agreement
Time of Update: 2019-08-15
Fosun Pharmaceutical released the announcement that on September 27, 2018, its holding subsidiaries Jinzhou AoHong Pharmaceutical Co., Ltd (AoHong pharmaceutical) and dia medica therapeutics of Canada
-
It only takes 63 working days for Shaanxi GMP certification from July 6
Time of Update: 2019-06-27
Medical network, June 27, June 26, the reporter learned from the provincial drug regulatory bureau that in order to further promote the reform of "release management service", optimize the GMP certifi
-
Notice of Jiangsu food and Drug Administration on receiving the approval from the State Administration
Time of Update: 2019-05-23
Recently, Jiangsu Province announced that four companies, Yangzi River, Ruier and Zhengda Tianqing, Nanjing Haichen, went to the State Administration for approval Including: montmorillonite powder, ba
-
Howson has come to apply for listing of class 1 "TiNi" new drugs! Hengrui, Zhengda Tianqing imitated and attacked, pressing the cardiovascular market
Time of Update: 2019-04-22
Highlight 1.2 collinear drugs are proposed to be included in the priority review; another member of desenol biological anti HIV drug is added, which weighs heavily on the compound preparation; 2 Xinli
-
Weigh! Three ministries and commissions list all fentanyl substances as drugs
Time of Update: 2019-04-02
Recently, the Ministry of public security, the National Health Commission and the State Drug Administration jointly issued the announcement on the inclusion of fentanyl substances in the supplementary
-
Shanghai's "4 + 7" volume procurement and new deal! The demonstration effect will be released
Time of Update: 2019-02-21
[policies and regulations of chinapharma.com] on February 19, Shanghai issued the notice on doing a good job in the pilot work of centralized purchasing and use of drugs organized by the state (herein
-
General Administration of market supervision and administration of the people's Republic of China interviewed CCTV on suspected advertising violations
Time of Update: 2019-01-18
On January 17, the General Administration of market supervision held an interview with the Central Radio and television administration on the issue that the advertising terms of "CCTV national brand p
-
When the Municipal Bureau of supervision and administration of the people's Republic of China again launched a bid to raise the price of chlorpheniramine API, an enterprise was fined more than 10
Time of Update: 2018-12-29
On December 28, Erkang pharmaceutical announced that its wholly-owned subsidiary Erkang pharmaceutical had received the notice of administrative penalty issued by the State Administration of market su
-
Why didn't the amendment to the drug administration law pass
Time of Update: 2018-10-29
On the afternoon of October 26, the sixth session of the Standing Committee of the 13th National People's Congress closed at the Great Hall of the people in Beijing After voting, the meeting adopted 1
